Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel
Authors:
- Maria Rosa GascoMGMaria Rosa Gasco
- 1 December 2000
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 210 (1-2) , 61-67
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to ratsPharmacological Research, 2000
- Preparation and characterization of solid lipid nanospheres containing paclitaxelEuropean Journal of Pharmaceutical Sciences, 2000
- Development of Novel Chitosan Derivatives as Micellar Carriers of TaxolPharmaceutical Research, 1998
- Cytotoxicity of Solid Lipid Nanoparticles as a Function of the Lipid Matrix and the SurfactantPharmaceutical Research, 1997
- Long acting injectable oxytetracycline-liposphere formulationsInternational Journal of Pharmaceutics, 1995
- Solid lipospheres of doxorubicin and idarubicinInternational Journal of Pharmaceutics, 1993
- P-glycoprotein and resistance to anticancer drugsCancer, 1992
- Polyalkylcyanoacrylate nanoparticles as drug carrier: present state and perspectivesJournal of Controlled Release, 1991
- Analysis of Macromolecular Polydispersity in Intensity Correlation Spectroscopy: The Method of CumulantsThe Journal of Chemical Physics, 1972
- An X-ray examination of long-chain alkyl dihydrogen phosphates and dialkyl hydrogen phosphates and their sodium saltsJournal of the Chemical Society (Resumed), 1955